已发表的部分文献: 标题:Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.作者:Katz TA, Vasilatos SN, Harrington E, Oesterreich S, Davidson NE, Huang Y;杂志名称:Breast Cancer Res Treat 标题:Epigenetic assays for chemical biology and drug discovery.作者:Gul S;杂志名称:Clin Epigenetics 标题:4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis.作者:Li W, Huang BS, Xiong YY, Yang LJ, Wu LX;杂志名称:Cancer Cell Int 标题:TNFα Induces DNA and Histone Hypomethylation and Pulmonary Artery Smooth Muscle Cell Proliferation Partly via Excessive Superoxide Formation.作者:Crosswhite P, Sun Z;杂志名称:Antioxidants (Basel) Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。